Monitoring of CD4/CD8 ratios should not be abandoned as HIV treatment programmes switch to streamlined monitoring, researchers from the University of Wisconsin argue in the journal AIDS.
Highlighting recently published research that shows the value of CD4/CD8 ratios for predicting who is at greater risk of cancer and weak vaccine responses, they say that the CD4/CD8 ratio remains an important biomarker for guiding individualised care in people with HIV.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
-
TheBodyPro: A new study on HIV, hypertension, and pregnancy is about a lot more than it seems
-
[CROI 2026] TheBodyPro: Why chronic inflammation drives multimorbidity in people with HIV, despite viral suppression
-
TheBodyPro: HIV-associated lipodystrophy persists as a health concern in the modern ART era
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.